Wealth Minerals Ltd. (TSXV:WML)

CTI BioPharma Income Statement

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Selling, General & Admin	1.98	2.64	3.23	4.24	2.34	2.16
Operating Expenses	44.02	46.86	10.76	11.06	4.37	6.49
Operating Income	-44.02	-46.86	-10.76	-11.06	-4.37	-6.49
Interest Expense	-	-	-	-0.01	-0.18	-0.24
Earnings From Equity Investments	-	-0.29	-0.6	-3.81	-1.37	-0.25
Currency Exchange Gain (Loss)	0.06	-0.01	0.04	0.12	0.05	0.04
Other Non Operating Income (Expenses)	-0.52	-0.61	0.79	3.77	-2.56	-0.7
EBT Excluding Unusual Items	-44.48	-47.76	-10.54	-10.99	-8.43	-7.64
Gain (Loss) on Sale of Investments	-3.65	-4.47	0.12	6.24	0.03	0.01
Gain (Loss) on Sale of Assets	-	-	-	-	-	1.77
Other Unusual Items	-	0.01	-0	0.09	-0.98	-
Pretax Income	-48.13	-52.22	-10.42	-4.66	-9.38	-5.86
Earnings From Continuing Operations	-48.13	-52.22	-10.42	-4.66	-9.38	-5.86
Minority Interest in Earnings	-	-	-	-	-	0.54
Net Income	-48.13	-52.22	-10.42	-4.66	-9.38	-5.33
Net Income to Common	-48.13	-52.22	-10.42	-4.66	-9.38	-5.33
Shares Outstanding (Basic)	337	331	319	270	207	153
Shares Outstanding (Diluted)	337	331	319	270	207	153
Shares Change (YoY)	3.49%	4.05%	17.95%	30.28%	35.83%	14.73%
EPS (Basic)	-0.14	-0.16	-0.03	-0.02	-0.05	-0.03
EPS (Diluted)	-0.15	-0.16	-0.03	-0.02	-0.05	-0.03
Free Cash Flow	-3.75	-5.24	-7.68	-7.24	-5.55	-2.53
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.03	-0.03	-0.02
EBITDA	16.64	-6.27	-10.31	-11.06	-4.37	-2.46
D&A For EBITDA	60.67	40.59	0.45	0	0	4.03
EBIT	-44.02	-46.86	-10.76	-11.06	-4.37	-6.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.